MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression aft ...
While the SUV segment has been growing, other segments are also important to the company to maintain high market share, Maruti Suzuki India (MSI) MD and CEO Hisashi Takeuchi told reporters here. "The ...
Motorola’s higher-growth, higher-margin, software-related businesses are becoming a larger portion of overall revenue. This will expand firmwide margins and opens a long runway of potential ...